Antiulcerant Drugs Market to Reach US$ 51.01 Billion by 2031 The Antiulcerant Drugs Market is witnessing steady growth due to the rising prevalence of gastric ulcers, acid reflux, and other gastrointestinal disorders. Increasing awareness about digestive health and improved access to healthcare services are driving demand for effective ulcer treatment medications. Pharmaceutical companies continue to focus on developing advanced therapies to improve...
0 Compartilhamentos
1881 Visualizações